JUSTIN HOVEY: Open Payments
NPI 1801970116 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$29,586 in 66 payments from 15 companies in 2025. Trend: 2023 $11,274 · 2024 $5,939 · 2025 $29,586
Speaker / faculty: $28,693Food & beverage: $894
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 28 | $25,926 |
| Phathom Pharmaceuticals, Inc. | 6 | $2,917 |
| Janssen Pharmaceuticals, Inc | 5 | $218 |
| ABBVIE INC. | 8 | $140 |
| Novo Nordisk Inc | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Merck Sharp & Dohme LLC | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| PFIZER INC. | 2 | $42 |
| Averitas Pharma Inc. | 1 | $22 |
Products named: ZEPBOUND, VOQUEZNA, SPRAVATO, VRAYLAR, REXULTI, VERQUVO, QULIPTA, MOUNJARO.
Industry payments across AL — which companies pay providers there.
